Chla/Myco Pneumo r-gene® - SFDA Registration ME0000001030SFDAA00230

Genic Detection Kit

Chlamydophila pneumoniae and Mycoplasma pneumoniae are bacteria frequently found among pathogenic agents responsible for atypical pneumopathies. They represent a high proportion (from 25 to 50%) of pneumopathies listed, even in hospitals. Our Chla/Myco pneumo r-gene™ kit is a duplex detection of both Chlamydophila pneumoniae and Mycoplasma pneumoniae. This product relies on the 5’ nuclease Real-Time PCR technology and thus utilizes its sensitivity and specificity. Chla/Myco pneumo r-gene™ belongs to the Respiratory MWS r-gene™ range of real-time PCR products for the detection of infectious agents (RSV, hMPV, Influenza A, Influenza B, Rhinovirus, Enterovirus, Adenovirus, Bocavirus, Coronavirus, Parainfluenza, ...). Each kit is a duplex PCR designed to detect specific targets from the same extracted sample, with a protocol and an amplification program that are common to all the Respiratory MWS r-gene™ products. Our kit, Chla/Myco pneumo r-gene™, is user-friendly as it offers ready-to-use reagents. All your results will be validated with the positive and negative controls provided in the kit. A cellular control will also validate the sample quality and the whole process, from extraction to amplification. The detection of this cell control is possible when using simultaneously our kit Rhino&EV/Cc r-gene™ (ref. : 71-042) or our CELL control r-gene™ (ref. : 71-106.. The major extraction and amplification platforms have been validated with all the products of the Respiratory MWS r-gene™ range. Methods for DNA amplification using Polymerase Chain Reaction (PCR), RT-PCR process and 5’ nuclease are covered by US patents issued to Hoffman-La Roche. Neither anything in this publication nor purchase of this product from Argene should be construed as an authorization or implicit license to use these methods.